O. A. Dagıstan Et Al. , "Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.," Pharmaceutics , vol.14, no.11, 2022
Dagıstan, O. A. Et Al. 2022. Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.. Pharmaceutics , vol.14, no.11 .
Dagıstan, O. A., Sevim, M., Sen, L. S., Basarir, N. S., Culha, M., Erturk, A., ... Fael, H.(2022). Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.. Pharmaceutics , vol.14, no.11.
Dagıstan, Özlem Et Al. "Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.," Pharmaceutics , vol.14, no.11, 2022
Dagıstan, Özlem A. Et Al. "Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.." Pharmaceutics , vol.14, no.11, 2022
Dagıstan, O. A. Et Al. (2022) . "Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.." Pharmaceutics , vol.14, no.11.
@article{article, author={Özlem AKBAL DAĞISTAN Et Al. }, title={Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.}, journal={Pharmaceutics}, year=2022}